Shardul Amarchand Mangaldas & Co. Advises ChrysCapital And Client Associates Alternate Fund On Secondary Investment Of Healthkart

Shardul Amarchand Mangaldas & Co. advises ChrysCapital and Client Associates Alternate Fund on the Secondary Investment of Bright Lifecare Private Limited (HealthKart) and also acted as the advisor to Bright Lifecare Private Limited in its recent investment round

20 November 2024 | New Delhi: Shardul Amarchand Mangaldas & Co. advised ChrysCapital and Client Associates Alternate Fund on the purchase of certain securities of Bright Lifecare Private Limited (HealthKart). Shardul Amarchand Mangaldas & Co. also advised HealthKart in the investment round led by ChrysCapital & Motilal Oswal Alternates. The overall investment round is valued at approximately USD 153 million.

As part of the deal, ChrysCapital and Client Associates Alternate Fund acquired stakes in HealthKart, a leading player in the healthcare sector, with a focus on scaling its operations in India’s rapidly growing healthcare market.

The transaction team representing ChrysCapital and Client Associates Alternate Fund was led by Gunjan Shah, Partner; Karun Prakash, Partner; Sangamitra Sankaraiah, Partner; Devaditya Chakravarti, Counsel; Simran Khullar, Senior Associate and Sukoon Dinodia, Associate.

The transaction team representing HealthKart was led by Manish Gupta, Partner, Nikita Goyal, Partner, Rashi Singh, Principal Associate, Vivek Tiwari, Senior Associate and Ananya Vajpeyi, Associate.

Avendus Capital acted as the exclusive financial advisor to HealthKart and its shareholders on the transaction.

EY India advised ChrysCapital on the financial and tax aspects.